LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
24th FDA Approval for Butchertown Clinical Trials August 4, 2025 LENZ Therapeutics, Inc. announced the US Food and Drug Administration (“FDA”) approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and…